北米のスマート吸入器市場予測2019-2028

◆英語タイトル:NORTH AMERICA SMART INHALERS MARKET FORECAST 2019-2028
◆商品コード:INK20AG069
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年7月
◆ページ数:124
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:北米
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥130,000見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥156,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥208,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGSThe North America smart inhalers market is predicted to register a CAGR of 31.01% over the projected period, 2019-2028. Technological developments, as well as competition among important pharmaceutical players, are augmenting market growth in the region.

MARKET INSIGHTS
The North America smart inhalers market growth is assessed through the countries of the United States and Canada. In Canada, total healthcare spending was estimated to reach USD xx billion or USD xx per person. It exhibits about 11.3% of the country’s GDP. In Canada, the primary factor boosting the growth of respiratory devices is the surging incidence of respiratory diseases. The patients suffering from COPD in the age group of 50 to 64 years were 261,000 in 2016 as per the statistics of Canada. It increased to 314,400 the next year. According to the Ontario Lung Association, asthma accounts for about 80% of chronic respiratory diseases in Canada. Some of the renowned companies established in Canada supplying nebulizers are PARI, MedQuip, Sunset, Respironics, among others. The prices range from low CAD 25 to CAD 190, based on the severity of diseases. The MDI is increasingly advised in schools and colleges among children, due to its better efficiency, rapid administration, and fewer side effects. However, the nebulizer is expected to be preferred over MDI in long term care, as it is less expensive and easily available. The mesh nebulization technology is becoming popular in various hospitals across Canada, leading to cost savings and superior performance, in turn, fueling market growth.

COMPETITIVE INSIGHTS
Some of the well-established companies functioning in the market are Teva Pharmaceutical Industries Limited, 3M Company, Agilent Technologies, Inc, Opko Health Inc, Koninklijke Philips N.V., etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. RISE IN AIR POLLUTION
3.2.2. HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES
3.2.3. SURGING INDOOR AIR POLLUTANTS
3.2.4. RISING GERIATRIC POPULATION
3.2.5. GROWING PREVALENCE OF COPD AND ASTHMA
3.3. KEY RESTRAINTS
3.3.1. DATA SECURITY CONCERN HAMPERS THE MARKET
3.3.2. HIGH COST OF ASTHMA AND COPD TREATMENT
4. KEY ANALYTICS
4.1. PORTER’S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER’S POWER
4.1.4. SUPPLIER’S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. EVOLUTION OF SMART INHALERS
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. KEY INVESTMENT INSIGHTS
5. MARKET BY PRODUCT
5.1. SMART INHALERS
5.2. SMART NEBULIZER
5.2.1. TYPES OF NEBULIZER (QUALITATIVE)
5.2.1.1. PNEUMATIC NEBULIZER
5.2.1.2. ULTRASONIC NEBULIZER
5.2.1.3. MESH NEBULIZER
5.2.2. NEBULIZER BY PORTABILITY (QUALITATIVE)
5.2.2.1. TABLETOP NEBULIZER
5.2.2.2. PORTABLE NEBULIZER
5.2.3. NEBULIZER BY SALES CHANNEL (QUALITATIVE)
5.2.3.1. DIRECT PURCHASE
5.2.3.2. ONLINE PURCHASE
6. MARKET BY INDICATION
6.1. ASTHMA
6.2. COPD
7. MARKET BY DISTRIBUTION CHANNEL
7.1. HOSPITAL
7.2. PHARMACY
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. THE UNITED STATES
8.1.2. CANADA
9. COMPANY PROFILES
9.1. 3M COMPANY
9.2. ADHERIUM LIMITED
9.3. AGILENT TECHNOLOGIES INC
9.4. ASTRAZENECA PLC
9.5. BOEHRINGER INGELHEIM GMBH
9.6. COHERO HEALTH INC
9.7. GLAXOSMITHKLINE PLC
9.8. KONINKLIJKE PHILIPS N.V
9.9. NOVARTIS AG
9.10. OPKO HEALTH INC
9.11. RESMED INC (PROPELLER HEALTH)
9.12. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
9.13. VECTURA GROUP PLC

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - SMART INHALERS
TABLE 2: NORTH AMERICA SMART INHALERS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 3: NORTH AMERICA SMART INHALERS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 4: NORTH AMERICA SMART INHALERS MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 5: NORTH AMERICA SMART INHALERS MARKET, BY INDICATION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 6: NORTH AMERICA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 7: NORTH AMERICA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 8: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 9: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[北米のスマート吸入器市場予測2019-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆